Michael M. Boyiadzis – författare
1 897 kr
Läs direkt efter köp
The Essential Therapy Guide to Cancer, Hematologic Disorders, and Supportive Care--Updated with the Latest Treatment Regimens
More than 500 treatment regimens
A Doody’s Core Title for 2019!
Hematology-Oncology Therapy, Second Edition is an up-to-date, comprehensive therapy guide that delivers more than 500 treatment regimens in a succinct, uniformmanner. The unique tabular design allows you to instantly locate and implement the proper treatment regimen. Supported by the latest practice guidelines, peer-reviewed literature, and the opinion of experts, Hematology-Oncology Therapy integrates extensive informationthat is critical to both office- and hospital-based practice of hematology and oncology.
Hematology-Oncology Therapy is divided into three sections:
Oncology:Provides detailed information about the administration, supportive care, toxicity, dose modification, monitoring, and efficacy of commonly used and recently approvedchemotherapeutic regimens, drugs, and biological agents
Supportive Care, Drug Preparation, Complications, and Screening:Consists of topics commonly encountered in clinical hematology-oncology practice, such as chemotherapy-induced nausea, oncologic emergencies, radiation complications, cancer pain management, cancer screening, and much more
Selected Hematologic Diseases:Delivers an authoritative guide to therapy for the principal diseases in consultative hematology
This edition of Hematology-Oncology Therapy is enriched by the updating of all chapters as well as the addition of several new chapters; the new "Expert Opinion," which provides recommendations and guidance from experts on the use of treatment regimens; and inclusion of the latest regimens.
3 654 kr
Läs direkt efter köp
The essential therapy guide to cancer, hematologic disorders, and supportive care—updated with the latest treatment regimens
A Doody''s Core Title for 2024, 2023 & 2022!
Hematology-Oncology Therapy, Third Edition, is an up-to-date, comprehensive therapy guide that delivers more than 800 treatment regimens in a succinct, uniform format. Supported by the latest practice guidelines, peer-reviewed literature, and insights from experts in the field, this peerless resource integrates extensive information critical to both office- and hospital-based practice of hematology and oncology.
Hematology-Oncology Therapy is divided into four sections:
Cancer Regimens: Covers administration, toxicity, dose modification, monitoring, supportive care, and the efficacy of commonly used and recently approved therapeutic regimens, and includes expert opinion and critical information on epidemiology, pathology, work-up, and staging, as well as survival dataAntiemetics, Growth Factors, Dose Modification and Drug Preparation: Provides in-depth coverage of antiemetics, growth factors, and the administration and formulation of anti-cancer drugsSupportive Care, Complications, and Screening (online): Offers thorough coverage of topics commonly encountered in clinical hematology-oncology practiceSelected Hematologic Diseases (online): provides an authoritative guide to therapy for principal diseases in consultative hematologyThe entire content is now online at AccessHemOnc.com. The online platform created for the third edition will be continually updated, including newly approved regimens.
2 926 kr
Läs direkt efter köp
The most succinct, user-friendly radiation-oncology therapy guide delivers up-to-date regimens in clear and easy-to-understand ways
The unique tabular design of Radiation-Oncology Therapy enables you to instantly locate and implement the proper radiation treatment regimen. Supported by the latest practice guidelines, peer-reviewed literature, and expert insights, this trusted guide integrates critical information for both office- and hospital-based practices. Every chapter includes relevant information for each cancer (epidemiologic data, per stage) and survival data; the role of radiation-oncology for each cancer stage; color images of radiation planning per stage; and tabular form specific information for each regimen. And each regimen includes patient population studied and journal reference, dose and duration, planning techniques, efficacy and outcomes, toxicities and dose modification, and supportive care.